Explore Your Local Site

Looks like you've landed on our   site. Let's take you home:    

Please note that the content and products on the    site might not be available in your region.

 

Choose the language:

  Homepage
Continue on the current website:  

 

Accessibility Statement

This is the accessibility statement for the CalanticTM Digital Solutions UK website (www.calantic.com/en-uk).

We want as many people as possible to be able to use this website. This means you should be able to:

  • Change colours, contrast levels and fonts using browser functionality
  • Zoom in up to 400 per cent without the text spilling off the screen
  • Navigate most of the website using just a keyboard

We also try to make the website text as clear as possible to understand.

 

How accessible is this website

We know from several accessibility reports that parts of this website are not yet fully accessible.

 

PDFs

Many of our PDFs are not fully accessible to screen reader software. PDF documents on the Calantic website are also available as HTML content.

Other parts of the website that are not fully accessible

These include:

  • some documents have poor colour contrast
  • links to websites or software that we do not own or manage and so cannot guarantee their accessibility

 

Feedback and Contact Information

We’re always looking to improve the accessibility of this website.

Contact us if you have an accessibility query including:

if you have any problems accessing information or using this website which you would like to report, you find any problems not listed on this page or think we’re not meeting accessibility requirements.

If you have any positive feedback about this website's accessibility.

 

Technical information about this website’s accessibility

We’re committed to making this website accessible, in accordance with the accessibility guidelines.

 

Compliance status

This website was checked on 20 September 2023 against the Web Content Accessibility Guidelines (WCAG) 2.1 AA standard.

Based on this testing, this site is partially compliant with WCAG 2.1 AA. This means there are some things which are not fully accessible.

 

Non-accessible content

The content that is not accessible is listed below together with an explanation and reference to the relevant WCAG section.

 

PDFs

The structure of the content is not always available to assistive technology, which makes the content difficult to understand and navigate for users of screen readers (Info and relationships 1.3.1).

The reading order of the content is not always logical, which means some content does not make sense when read out by text-to-speech software.

Images do not always have text alternatives, which means some content is not available when using text-to-speech software.

 

Images

Some images are missing alternative text descriptions meaning they are not announced by screen readers (Text alternatives 1.1).

 

Preparation of this accessibility statement

This statement was updated in September 2023.

This website’s accessibility will be reviewed on a regular basis.

We will continue to update this accessibility statement with any relevant changes.

Bayer Logo
  • United Kingdom

© 2024 Bayer

The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.

This is intended to provide information for healthcare professionals and other relevant decision makers in the European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

 

Calantic is ISO 27001 certified. The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals

 

You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

 

CO-CALA-GB-0001 December 2024